Total number of knee arthroplasty operations is increasing. Blood loss, long hospital stay, postoperative morbidity and delay in postoperative rehabilitation are well known complications of this procedure. [1] There are studies in the literature with hemostatic agents and researches are still ongoing. Antifibrinolytic drugs such as tranexamic acid (TA) have been used in elective orthopedic surgeries to reduce bleeding and blood transfusions perioperatively. [2] Although there is a consensus on this positive effect of TA, it is not known what kind of effect TA has on the surrounding tissues, especially when applied to quadriceps.
Tranexamic acid is used intravenously (IV) and orally for the purpose of stopping excessive bleeding or facilitating clotting in emergency services and postoperatively. Topical use was recognized by the use of otolaryngology doctors. In the field of orthopedics and traumatology, intraarticular use was found to reduce bleeding and consequently blood transfusion in the perioperative period. [2, 3] Scientific demonstration of the effect of TA on tendons as well as the positive effect of TA on local bleeding with multiple tendon injuries and local application during joint surgery involving many tendons will contribute to the literature on the use of this material, which has been used frequently in recent years. However, to our knowledge, there is no study about the effect of local application of TA on tendon healing. This study was performed using the well-known rat tendon injury model. [1, 4] In this study, we aimed to evaluate the potential adverse effects of TA on tendon healing.
MATERIALS AND METHODS
The study was conducted at Ondokuz Mayıs University between November 2016 and May 2017 with the approval of the local Ethics Committee (Ordu University) of experimental animals (dated 12.05.2016, number 4/decision 8). The study was conducted in accordance with the principles of Care and Use of the Laboratory Animals and the animal rights were protected. Twelve male Wistar-Albino rats (weighing 300 g to 350 g) were divided into two groups so that the weights of the animals were close to each other. The right legs of the rats were determined as the TA group and the left legs as the serum physiologic (SP) group. Half of the rats were sacrificed at the third week (right leg-TA3, left leg-SP3) and the other half at sixth week (right leg-TA6, left leg-SP6) and tendon samples were collected from the extremities. The reason for taking the samples at third and sixth weeks of the study was to determine the effect of TA on hemostasis-inflammation, which is the first phase of healing, and subsequent proliferationangiogenesis phases. Wound dressing was performed. During the experiment, rats were kept at normal room temperature and humidity by feeding with standard pellet feed and tap water for 10/14 hours in a light/dark cycle of light, three subjects per cage. After the surgical procedure, all animals were regularly treated with wound dressing. At third and sixth weeks, the rats were sacrificed.
All tendons were removed with the bone tissue adjacent exposing suture area and fixed with 10% buffered formaldehyde solution. Then, the samples were decalcified in 10% formic acid solution, histological tissue monitoring was performed and paraffin tissue blocks were prepared. Sections with a thickness of 5 μm were taken longitudinally from the blotted tissues. Hematoxylin and eosin, and Masson's trichrome and alcian blue staining were performed (Figures 2 and 3) . The samples were evaluated using the Bonar classification, a semiquantitative tendon scoring method. [5] Bonar classification consists of tenocyte morphology, degree of ground substance staining, collagen morphology, and vascularity parameters. Each parameter is evaluated between 0 and 3 points. Total tendon healing scores indicate that all parameters are evaluated together. In this classification, low scores indicate good tendon healing, whereas high scores indicate bad tendon healing.
Statistical analysis
The data (total tendon healing scores) were firstly analyzed using Levene's test and the ShapiroWilk test for equality of variance and normality assumption, respectively (p<0.05). Secondly, the differences between the TA and SP groups were analyzed by using Mann-Whitney U test. According to the results of this test, the data for SP3 and TA3, SP6 and TA6, SP3 and SF6, TA3 and TA6, respectively, were expressed as sample size, mean with standard deviation, median, interquartile range and minimum and maximum values. The results were accepted as significant at the level of p<0.05. All the statistical calculations were performed with the IBM SPSS version 22.0 (IBM Corp., Armonk, NY, USA) statistical program.
RESULTS
An examination of the Bonar classification parameters revealed that tenocyte cell morphology was better in the TA group than SP group at the third week. In terms of colloidal organization, SP groups gave superior results in all terms. An examination of the total tendon healing scores showed that the results were superior at the third week than at the sixth week in all groups. Tables 1 and 2 .
DISCUSSION
The most important finding obtained in this study was that local application of TA had negative effect on tendon healing in the late period. TA is thought to cause this situation by reducing angiogenesis in the initial phase of healing and formation of hematoma in the progressive phase. There is a consensus at the point that TA, which is frequently used in the current practice of orthopedics, reduces blood transfusion by reducing bleeding. [6] However, the lack of information on the effect of this agent on neighboring tissues makes this study remarkable in terms of creating awareness about its use.
Tranexamic acid has been previously used quite successfully in urological, gynecological, and thoracic surgical procedures to reduce postoperative blood loss. [7] The first use in orthopedic surgery was performed in 1997 by Akuzi et al., [8] who reported that they did not transfuse blood after 42 bilateral and 64 unilateral knee prostheses. Also, Konig et al. [9] first reported that they reduced transfusion rates. In their meta-analysis, Zufferey et al. [10] defined that TA reduced blood loss in major orthopedic surgeries. In accordance with this, Aydın et al. [1] reported that use of TA decreased the duration of hospital stay after surgery and total hospital costs.
Tranexamic acid can be administered intramuscularly, orally, IV or locally. [11] There are a number of studies in the literature concerning the perioperative use of TA in joint surgery for localized use of TA, ease of administration, maximum concentration on bleeding site, and reduced systemic risks due to low drug absorption. [7] In some studies, it has been shown that local administration is more effective than placebo and other administration methods. [6, 7, [12] [13] [14] Although the positive effects of TA are known, the chemical effect of the intraarticular application on the surrounding soft tissue is not known clearly. [6] There is no consensus on the amount and method of local application of TA. [12, 15] In recent studies related with joints, 2 g intraarticular administration of TA was more effective than other doses. [16] There are different methods of intraarticular application, such as applying the drug into the joint after wound closure, washing the joint with drug before wound closure, and injecting the drug into the joint through drain. [12, [16] [17] [18] [19] In this study, 1 mL TA was applied with an injector to allow its accumulation directly in the soft tissue in the wound after the skin was covered.
A limited number of studies with hemostatic agents are available in the literature. Similar to our findings, Aydın et al. [1] found significantly worse total tendon healing scores in their study with Ankaferd BloodStopper ® (Ankaferd İstanbul İlaç ve Sağlık Ürünleri AŞ, Istanbul, Turkey) in the TA group than in the SP group. Whereas He et al. [20] reported that the use of fibrin glue for flexor tendon repair in rabbit models improved adhesion in early period so it can be safely used for regeneration and healing purposes on this site. In this study, according to Bonar classification, total tendon healing scores in all third week groups were significantly superior when compared to all sixth week groups.
A study on fibroblast culture model compared three hemostatic agents (Ankaferd, fibrin glue, and TA) in terms of their effects on healing, and showed that all agents had negative effects on fibroblasts, with Ankaferd having the lowest values of cell proliferation, cell number, and viability. [21] Okumuş et al. [22] reported that Ankaferd did not lead to any degeneration of regional tissue and systemic tissues. In another study, Ankaferd had a significantly negative effect on colloid organization. [1] However, Cancan et al. [23] showed that topical Ankaferd had a positive effect on angiogenesis and improved colloid organization. In this study, although the tenocyte cell morphology in the third week TA group was better than the SP group, the SP groups in all weeks gave superior results in terms of colloid organization. Similar results were obtained in all groups in terms of basic substance and vasculancy.
In this study, an evaluation of the samples obtained in third and sixth weeks according to Bonar classification revealed that the healing score observed in the tendons in the third week was superior to that of the sixth week. Also, an analysis of the TA group showed that the tenocytes had more round nuclei and greater amount of cytoplasm in the third week. However, in the sixth week, we detected that the tenocyte nuclei became round more specifically, the cytoplasm increased, and areas of chondroid metaplasia formed locally. This condition may indicate that tendon healing in the third week was better compared to the sixth week. In tendon healing, a low mean of total scoring is preferred. However, the means of total scoring in TA and SP groups were found to be high, which led us to interpret that TA may be affecting tendon healing negatively in the late period. This effect may have resulted from the used dosage, and administration method.
There are some limitations of this study. First is the lack of biomechanical analyses. Although histological evaluation is important for tendon healing process, biomechanical test results are also important for the evaluation of tendon repairs. A second limitation is the lack of markers about immunohistochemical evaluation. Lastly, the applied TA in this study, which may have resulted in a pure and nonhomogeneous application into tissues unlike clinical applications, may have caused study-clinical incompatibility.
In conclusion, the results of this study showed a late adverse effect of local TA on tendon healing. TA may cause delayed healing by reducing hemorrhage and adversely affecting the healing phases of hemostasisinflammation and proliferation-angiogenesis. This might lead to clinically weak-late recovery, inadequatelate rehabilitation and delayed return to social life and work. The results of this study may bring a new perspective on the use of TA at orthopedic and other surgical procedures. Further studies including biomechanical and immunohistochemical studies are needed to investigate the effects of TA application on tendon healing.
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